Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results

Benzinga Earnings

06/30

Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.

Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.

"Our second quarter marked an acceleration in many areas in the evolution of our business," said Chris Caldwell, CEO of Concentrix.

Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.

Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.

These analysts made changes to their price targets on Concentrix following earnings announcement.

Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.
Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.

Considering buying CNXC stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2647838557"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2647838557\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2647838557?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2647838557","market":"hk","top_or_hot":-1,"title":"Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results","media":"Benzinga Earnings","content":"<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Concentrix Analysts Slash Their Forecasts After Downbeat Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConcentrix Analysts Slash Their Forecasts After Downbeat Q2 Results\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2026-06-30 22:45</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong><a href=\"https://laohu8.com/S/CNXC\">Concentrix Corp</a> </strong>(NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.</p>\n<p>Concentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.</p>\n<p>\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.</p>\n<p>Concentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.</p>\n<p>Concentrix shares dipped 18.2% to trade at $20.64 on Tuesday.</p>\n<p>These analysts made changes to their price targets on Concentrix following earnings announcement.</p>\n<ul>\n<li>Baird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.</li>\n<li>Barrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.</li>\n</ul>\n<p><strong>Considering buying CNXC stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"483\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-1024x483.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-300x141.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833-768x362.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/06/30104453/image-833.png 1192w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065170008.USD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/06/60189980/concentrix-analysts-slash-their-forecasts-after-downbeat-q2-results","article_id":"2647838557","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2647838557","pubTimestamp":1782830756,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Concentrix (CNXC) reports lower-than-expected Q2 earnings and cuts FY26 guidance. Analysts lower price targets. Stock falls 18.2% to $20.64.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","BK4226":"数据处理及外包服务","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","CNXC":"Concentrix Corp","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4106":"数据处理与外包服务"},"translate_title":"Concentrix分析师在第二季度业绩悲观后大幅下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNXC":1},"content_text":"Concentrix Corp (NASDAQ:CNXC) on Monday reported worse-than-expected second-quarter financial results and cut its FY26 guidance below estimates.\nConcentrix reported quarterly earnings of $2.63 per share, which missed the analyst consensus estimate of $2.64, according to Benzinga Pro data. Quarterly revenue came in at $2.46 billion, which missed the consensus estimate of $2.47 billion by 0.44%.\n\"Our second quarter marked an acceleration in many areas in the evolution of our business,\" said Chris Caldwell, CEO of Concentrix.\nConcentrix lowered its fiscal 2026 adjusted EPS guidance to between $10.83 and $11.18, versus the $11.97 analyst estimate, and lowered its revenue outlook to $9.93 billion to $10.03 billion, versus the $10.14 billion estimate.\nConcentrix shares dipped 18.2% to trade at $20.64 on Tuesday.\nThese analysts made changes to their price targets on Concentrix following earnings announcement.\n\nBaird analyst David Koning maintained the stock with an Outperform rating and lowered the price target from $40 to $30.\nBarrington Research analyst Vincent Colicchio maintained the stock with an Outperform rating and lowered the price target from $38 to $30.\n\nConsidering buying CNXC stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}